What To Consider When Adding DLS To Your Early Biologics Development Workflow
Source: NanoTemper Technologies, Inc.

Dynamic Light Scattering (DLS) is a versatile and simple tool used for assessing the colloidal stability of drug candidates early in protein-based therapeutic development. Like any tool or technology, when you move from theory to practice, questions arise — whether they’re about how to add the tool to a workflow, or what the experimental data tells you about your candidates.
Read on to find the answers to questions your early development scientist peers have asked about how to use DLS to design, select, and advance the most stable biologics candidates.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
NanoTemper Technologies, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more